The fundamental goal of the Driving Biomedical Projects (DBPs) portfolio is to provide synergism, motivation, and act as a catalyst that drives the Washington University (WU) Biomedical Mass Spectrometry (MS) Resource personnel to develop and advance novel MS technologies, techniques, and methods (i.e., TRDs) that overcome technical challenges that inhibit progress on critical biomedical research questions or the biomolecular basis for a significant clinical disorder. Our DBPs provide a challenging biological platform or context upon which we can test, develop, refine, enhance, and advance new MS technologies and techniques. DBPs give purpose and compel Resource personnel to brainstorm, develop, custom-design, test, and apply MS technology and techniques in novel and innovative directions. When successful, they provide for the biomedical research community new tools that can be applied to solve intractable analytical problems. Our DBP portfolio has been carefully integrated with our proposed TRD themes, and includes 7 new, 29 ongoing, and 30 DBPs completed from 2009-13.

Public Health Relevance

-Public Health Relevance. The Washington University Biomedical Mass Spectrometry Resource has a longstanding history as an active and productive citizen in the NIH Biotechnology Research Resources community. We propose to extend our mission by advancing mass spectrometry technology, development, and research, applying these discoveries to answer critical biomedical research questions, and training the next generation of researchers, towards the ultimate goal of improving public health.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Biotechnology Resource Grants (P41)
Project #
5P41GM103422-40
Application #
9199438
Study Section
Special Emphasis Panel (ZRG1-IMST-B)
Project Start
Project End
Budget Start
2017-01-01
Budget End
2017-12-31
Support Year
40
Fiscal Year
2017
Total Cost
$131,639
Indirect Cost
$45,318
Name
Washington University
Department
Type
Domestic Higher Education
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Keul, Nicholas D; Oruganty, Krishnadev; Schaper Bergman, Elizabeth T et al. (2018) The entropic force generated by intrinsically disordered segments tunes protein function. Nature 563:584-588
Goldner, Nicholas K; Bulow, Christopher; Cho, Kevin et al. (2018) Mechanism of High-Level Daptomycin Resistance in Corynebacterium striatum. mSphere 3:
Zhang, Bojie; Cheng, Ming; Rempel, Don et al. (2018) Implementing fast photochemical oxidation of proteins (FPOP) as a footprinting approach to solve diverse problems in structural biology. Methods 144:94-103
Su, Zhaoming; Wu, Chao; Shi, Liuqing et al. (2018) Electron Cryo-microscopy Structure of Ebola Virus Nucleoprotein Reveals a Mechanism for Nucleocapsid-like Assembly. Cell 172:966-978.e12
Zhang, Mengru Mira; Rempel, Don L; Gross, Michael L (2018) A Fast Photochemical Oxidation of Proteins (FPOP) platform for free-radical reactions: the carbonate radical anion with peptides and proteins. Free Radic Biol Med 131:126-132
Shen, G; Li, S; Cui, W et al. (2018) Stabilization of warfarin-binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition. J Thromb Haemost 16:1164-1175
Lu, Yue; Goodson, Carrie; Blankenship, Robert E et al. (2018) Primary and Higher Order Structure of the Reaction Center from the Purple Phototrophic Bacterium Blastochloris viridis: A Test for Native Mass Spectrometry. J Proteome Res 17:1615-1623
Fernandez, Estefania; Kose, Nurgun; Edeling, Melissa A et al. (2018) Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus. MBio 9:
Johnson, Britney; VanBlargan, Laura A; Xu, Wei et al. (2018) Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability. Immunity 48:487-499.e5
Girard, T J; Grunz, K; Lasky, N M et al. (2018) Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology. J Thromb Haemost 16:2246-2257

Showing the most recent 10 out of 323 publications